Slide 1

Ross Bryan Medical Student MS III Mercer University August 2012 Effect of Supplementation With High-Selenium Yeast on Plasma Lipids Annals of Internal Medicine

Slide 2

Funding The Cancer Research Campaign (now Cancer Research UK) and the University of Surrey Funding for the original Pilot study fell through

Slide 3

Background/ Objective: Selenoproteins, such as glutathione peroxidase, have been shown to combat the oxidative damage caused by circulating lipids and reduce inflammation There is good scientific rationale for optimal selenoprotein levels, however, the evidence for selenium supplementation has been ambiguous

Slide 4

BACKGROUND CONTINUED Selenoproteins share a common biosynthetic pathway with cholesterol, although the pathways by which this alters lipid profiles is not clear.

Slide 5

Why is this important? 1) Higher LDL is associated with elevated risk for cardiovascular disease by participating in the formation of plaques in artery walls 2) Higher HDL is associated with lower risk for heart disease by transporting lipids back to the liver for excretion from the body Therefore, lipid profiles are important in determining the risk for heart and vascular disease

Slide 6

Atheromatous Plaque Formation

Slide 7

Study Design and Setting: A) Randomized Double-blind B) Placebo-controlled C) 4 parallel group study at locations in the UK D) Men and Women 60-74 years of age E) 6 month trial period

Slide 8

Endpoints included in analysis: 1)Total cholesterol 2)Non-HDL cholesterol 3)HDL cholesterol 4)Total-HDL cholesterol ratio

Slide 9

Exclusions: 1)Southwest Oncology Score < 1 2)HIV diagnosis 3)Active liver or kidney disease 4)Previous diagnosis of cancer 5)Diminished mental capacity 6)Receipt of selenium supplements (>50mcg/d)

Slide 10

Results:

Slide 11

Intention-to-treat analysis This study employs a method called intention to treat analysis This means that people who discontinued the treatments were still included in the analysis as long as they can be followed WHAT!?!?!?

Slide 12

ITT Preserves Randomization and Prevents Bias Consider a hypothetical experiment: Outcome --> X disease prevention Group 1 --> Medicine + Surgery (100 ppl) * surgery scheduled 1 month after randomization Group 2 --> Medicine (100 ppl)

Slide 13

ITT Hypothetical Experiment Group 1 -10/100 do not go through with surgery -5 of these suffer disease X in trial period -15/90 that have surgery suffer disease -If the ten that drop out are excluded: total disease risk = 15/90 = 16.7% Group 2 -5 get disease in first month -15 get disease in subsequent trial period total disease risk = 20/100 = 20%

Slide 14

Hypothetical Experiment Assumption Assumption:surgery is not effective: a) per protocol overestimates surgical benefits (16.7%) b) ITT is more accurate

Slide 15

Disclaimer ITT is controversial and has flaws Example: -what if surgery completely prevented disease X? -then, 5 ppl in group 1 would have been included in analysis as having disease -would underestimate benefit of surgery

Slide 16

Conclusion: Selenium supplementation was associated with modest reductions in total and non- HDL lipoprotein cholesterol levels. At higher doses, selenium was associated with increases in HDL cholesterol

Slide 17

Limitations: 1)Study fouses only on lipid profile and not cardiovascular disease risk 2)Triglyceride levels were not measured 3)Trial period was only 6 months 4)Small sample size 5)ITT analysis???

Slide 18

Comments: Although the trial demonstrated a small improvement in lipid profiles, the findings do not justify the use of selenium supplementation for treatment of dyslipidemia because of the listed limitations and possible side effects.

Slide 19

Citation Rayman, P. Margaret et al. Effect of Supplementation with High-Selenium Yeast on Plasma Lipids: A Randomized Trial. Ann Intern Med 2011 May 17; Volume 145 Number 10; pg.656-664.